GYG Gyg Plc

RNS Number:3920R
Gyrus Group PLC
22 September 2000



GYRUS GROUP PLC
('Gyrus' or the 'Group')

GYNECARE VERSAPOINT INSTRUMENTS TEMPORARILY WITHDRAWN FROM MARKET


Gyrus Group PLC has been notified by its marketing partner Ethicon Inc that
its subsidiary, Gynecare, intends to temporarily withdraw from the market the
GYNECARE VERSAPOINT hysteroscopic instruments manufactured by Gyrus.  

This decision was reached voluntarily following sporadic reports of gas
embolism (gas bubbles in the circulation) occurring during hysteroscopic
myomectomy (removal of fibroids) using the GYNECARE VERSAPOINT system.  There
have been no reports of these complications occurring during other
hysteroscopic procedures for which the GYNECARE VERSAPOINT system is currently
used.  

Whilst gas embolism is a well recognised complication of hysteroscopic surgery
using a variety of technologies, Ethicon considers that the specifics of the
circumstances surrounding these events are worthy of a full and thorough
assessment.

It is anticipated that following this assessment the product will be
reintroduced with appropriate technical and labelling changes to minimise any
future risk of the occurrences given the growing use of the system worldwide.

It is not currently anticipated that this situation will have a significant
impact on the Company's financial performance.

ENQUIRIES

Gyrus Group PLC                                   
John Bradshaw, Finance Director                     
Analyst/Broker/Shareholder Enquiries
Tel: (01628) 535 815
Fax: (01628) 535 801
E-Mail: john.bradshaw@gyrus.co.uk

Jean Garon PR                                   
Jean Garon                                          
Press Enquiries                                   
Tel: (01628) 483040
Fax: (01628) 486796
E-Mail: jean@garonpr.demon.co.uk

Gyg (LSE:GYG)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

Gyg (LSE:GYG)
Historical Stock Chart
Von Jul 2023 bis Jul 2024